Compositions and Methods for Treating Proliferation Disorders
申请人:Arqule, Inc.
公开号:US20160067260A1
公开(公告)日:2016-03-10
The present invention relates to methods of treating cell proliferative disorders, such as cancer or Proteus syndrome, by utilizing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine or 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-(3-morpholinophenyl)-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine or N-(1-(3-(3-(4-(1-aminocyclobutyl)phenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-5-yl)phenyl)piperidin-4-yl)-N-methylacetamide. The methods of the present invention can also relate to methods of treating cell proliferative disorders, such as cancer or Proteus syndrome, by utilizing the above compounds in combination with ((R)-6-(2-fluorophenyl)-N-(3-(2-((2-methoxyethyl)amino)ethyl)phenyl)-5,6-dihydrobenzo[h]quinazolin-2-amine).
Iodine‐Promoted Tunable Synthesis of 2‐Naphthyl Thioethers and 1‐Naphthyl Thioethers
作者:Yishu Bao、Xiuqin Yang、Zonghao Dai、Suyu Ji、Qingfa Zhou、Fulai Yang
DOI:10.1002/adsc.201801562
日期:2019.4.23
An iodine‐promoted regioselective sulfenylation/deoxygenation/aromatization reaction of 1‐tetralones with disulfides has been developed. This process could be modified to synthesize 2‐naphthyl thioethers and 1‐naphthyl thioethers in moderate to excellent yields, respectively. Furthermore, when the reaction was extended to 2‐tetralones, 2‐naphthyl thioethers were obtained as the sole products. The current
A catalyst-free, directelectrochemical synthesis of synthetically challenging medium-sized lactams through C–C bond cleavage has been developed. In contrast to previous typical amidyl radical cyclization, this electrosynthetic approach enabled step-economical ring expansion through a unique remote amidyl migration under mild, metal- and external-oxidant-free conditions in a simple undivided cell.
The present invention relates to substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.